- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.01. | NHS urges more young people to take up HPV vaccine | ||
| 26.01. | BHF data reveals early heart disease deaths rise to highest level | ||
| 25.01. | PlaqueTec and Babraham Institute partner for treatment of coronary heart disease | ||
| 25.01. | Researchers identify gene that causes heart defects in Down syndrome | ||
| 24.01. | Calluna Pharma announces €75m series A financing for immunological diseases | ||
| 24.01. | NHS to test new blood group genotyping test on inherited blood disorder patients | ||
| 23.01. | MIT researchers repurpose cancer compound to treat PKD | ||
| 23.01. | Researchers advance blood tests' ability to detect cancer earlier | ||
| 22.01. | NHS catch up campaign launched for missed MMR vaccines | ||
| 22.01. | Virtual reality training to help NHS doctors spot signs of sepsis | ||
| 19.01. | Stroke experts to test emerging nerve stimulation treatment | ||
| 19.01. | Serac to present data from DETECT study | ||
| 18.01. | UCB announces MHRA approval for UCB's Zilbrysq | ||
| 18.01. | Synendos receives EMA nod for brain therapy | ||
| 17.01. | StemSight and ERS Genomics focus on collaboration | ||
| 17.01. | Poolbeg's cytokine release syndrome candidate shows potential | ||
| 16.01. | Disco tunes into new cancer drug targets | ||
| 16.01. | Aston University receives £10m for membrane institute | ||
| 15.01. | CellVoyant secures £7.6 million AI stem cell boost | ||
| 15.01. | Kanabo and City Dock Pharmacy team up | ||
| 12.01. | Cambridge researchers begin new trial for oesophageal cancer screening | ||
| 12.01. | Study reveals antibiotic use is not the only driver of antibiotic resistance | ||
| 11.01. | New data reveals out-of-hospital cardiac survival results remain low in England | ||
| 11.01. | Inhalable sensor to make lung cancer screening more accessible worldwide | ||
| 10.01. | Barinthus Bio announces $47m project to advance MERS coronavirus vaccine |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
